Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mentor Consent Decree Mandates Facility Recertification By Consultant

This article was originally published in The Gray Sheet

Executive Summary

Mentor plans to complete by this fall the recertification of its breast implant production facility.

You may also be interested in...

Mentor consent decree vacated

Dallas federal court finds Irving, Texas facility to be in compliance with FDA GMP requirements, Santa Barbara company announces Sept. 8. Mentor entered into the consent decree in 1998. The enforcement action related to a breast implant production site (1"The Gray Sheet" May 11, 1998, p. 16)...

US FDA’s Unapproved Drug Initiative Nixed, But Without Agency Buy-In Demise May Be Short-Lived

Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts